Dr. Reddy's Laboratories Files Form 6-K
Ticker: RDY · Form: 6-K · Filed: Dec 23, 2024 · CIK: 1135951
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer, sec-filing
TL;DR
DRL filed a 6-K on 12/23/24, standard foreign issuer report.
AI Summary
Dr. Reddy's Laboratories Limited filed a Form 6-K on December 23, 2024, to report information as a foreign private issuer. The filing is in accordance with Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. The company is based in Hyderabad, Telangana, India, and its principal executive office is located at 8-2-337, Road No. 3, Banjara Hills.
Why It Matters
This filing indicates ongoing reporting compliance for Dr. Reddy's Laboratories, a significant player in the pharmaceutical industry, which is important for investors tracking the company's regulatory activities.
Risk Assessment
Risk Level: low — This is a routine regulatory filing by a foreign private issuer and does not contain new financial or operational information that would typically increase risk.
Key Players & Entities
- Dr. Reddy's Laboratories Limited (company) — Registrant
- 8-2-337, Road No. 3, Banjara Hills Hyderabad, Telangana 500 034, India (location) — Principal executive office address
- December, 2024 (date) — Filing period
- 20241223 (date) — Filing date
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
When was this Form 6-K filed?
The filing was made on December 23, 2024.
What is the primary business address of Dr. Reddy's Laboratories Limited?
The primary business address is 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
Does Dr. Reddy's Laboratories file annual reports under Form 20-F or Form 40-F?
Dr. Reddy's Laboratories indicates it files annual reports under Form 20-F.
What is the SIC code for Dr. Reddy's Laboratories?
The Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 405 words · 2 min read · ~1 pages · Grade level 16.9 · Accepted 2024-12-23 13:35:55
Filing Documents
- drr0707_6k.htm (6-K) — 13KB
- drr0707_ex99-1.htm (EX-99.1) — 6KB
- drr0707_ex99-1img01.jpg (GRAPHIC) — 4KB
- drr0707_ex99-1img02.jpg (GRAPHIC) — 6KB
- 0001575872-24-001272.txt ( ) — 33KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: December 23, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3